Opportunity Information: Apply for RFA 492 12 000030

  • The Philippines USAID Manila in the health sector is offering a public funding opportunity titled "Health Policy Development Project 2" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001 USAID Foreign Assistance for Programs Overseas.
  • This funding opportunity was created on Aug 7, 2012 and posted on Jun 27, 2012.
  • Applicants must submit their applications by Aug 10, 2012 Due to inclement weather, deadline for applications is extended to August 10, 2012, 300 P.M. Applications received after the extended closing date and time will not be reviewed.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $15,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • This funding opportunity is for local Philippine organizations only. Applicants may be local non governmental organizations and private for profit companies willing to forego profit. Universities and colleges that fit the criteria are also eligible to apply.
Apply for RFA 492 12 000030

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Health Policy Development Project 2 (HPDP2) is a USAID Manila-funded cooperative agreement designed to help the Philippines build a stronger, more sustainable health policy and financing environment. The core idea is to make it easier for the Philippine Government to meet major national and global health targets (including the Millennium Development Goals that were active at the time of the announcement) while also expanding and sustaining the country s universal health care initiative. HPDP2 focuses on improving the policy backbone behind key public health priorities, specifically family planning (FP), maternal, neonatal, child health, and nutrition (MNCHN), and tuberculosis (TB). Rather than delivering direct clinical services, the opportunity centers on strengthening the systems that shape how health programs are funded, governed, and improved over time.

The grant supports four main areas of work. First, it funds health policy research, advocacy, and the formulation of health policies, meaning the recipient is expected to generate evidence, translate it into practical recommendations, and help move those recommendations into formal policy decisions. Second, it invests in policy monitoring and evaluation, which involves tracking whether policies are being implemented as intended, measuring results, and identifying what needs to change to improve performance and accountability. Third, it includes capacity building aimed at accelerating health sector reforms, so the awardee would be expected to strengthen the skills, tools, and processes that government and partner institutions need to implement reforms more effectively. Fourth, HPDP2 emphasizes institutionalization of a multi-sectoral health policy institution, signaling an intent to create or strengthen a durable policy platform that brings together multiple sectors (not just health) to coordinate and sustain policy development over the long term.

From a funding and administrative standpoint, this opportunity is a discretionary award using a cooperative agreement mechanism, which generally indicates substantial involvement by the funding agency during implementation compared to a standard grant. USAID anticipated making one award with an estimated total funding amount of up to USD 15,000,000, and the award ceiling is also USD 15,000,000 (with an award floor of USD 0). Cost sharing or matching is required, so applicants would need to contribute resources or documented value in accordance with the announcement requirements. The CFDA number listed is 98.001, USAID Foreign Assistance for Programs Overseas.

Eligibility is limited to local Philippine organizations only. Eligible applicants include Philippine non-governmental organizations, local private for-profit companies that are willing to forego profit under the award, and universities or colleges that meet the criteria stated in the full announcement. The posting date was June 27, 2012, with an original closing date of August 8, 2012. Due to inclement weather, the deadline was extended to August 10, 2012 at 3:00 PM, and applications submitted after the deadline were not to be reviewed.

For access to the full announcement, the listing referenced Grants.gov, and the contact person provided for support was Gracelda M. Laspinas, Acquisition and Assistance Specialist at USAID Manila, reachable at manilahpdp2@usaid.gov.

Frequently Asked Questions (FAQs): Health Policy Development Project 2 (HPDP2)

1. What is HPDP2?

Health Policy Development Project 2 (HPDP2) is a USAID Manila-funded cooperative agreement intended to help the Philippines strengthen and sustain its health policy and health financing environment. The project is designed to make it easier for the Philippine Government to meet major national and global health targets (including the Millennium Development Goals that were active at the time of the announcement) while also expanding and sustaining the country's universal health care initiative.

2. What is the main purpose of this funding opportunity?

The opportunity focuses on strengthening the systems that shape how health programs are funded, governed, evaluated, and improved over time. It emphasizes policy development and financing improvements rather than the delivery of direct clinical services.

3. Which health areas does HPDP2 prioritize?

HPDP2 prioritizes strengthening the policy foundation behind key public health areas, specifically:

  • Family planning (FP)
  • Maternal, neonatal, child health, and nutrition (MNCHN)
  • Tuberculosis (TB)

4. Does HPDP2 fund direct clinical or medical services?

No. Based on the description provided, HPDP2 is not centered on delivering direct clinical services. The emphasis is on improving policies, monitoring and evaluation, capacity building for reforms, and institutionalizing multi-sectoral policy coordination.

5. What are the four main areas of work supported under HPDP2?

The grant supports four major areas:

  1. Health policy research, advocacy, and policy formulation (generating evidence, developing recommendations, and helping move them into formal policy decisions)
  2. Policy monitoring and evaluation (tracking implementation, measuring results, and identifying improvements for accountability and performance)
  3. Capacity building to accelerate health sector reforms (strengthening skills, tools, and processes needed to implement reforms effectively)
  4. Institutionalization of a multi-sectoral health policy institution (creating or strengthening a durable platform that brings multiple sectors together to coordinate and sustain policy development)

6. What does it mean that this opportunity uses a cooperative agreement?

This opportunity is offered through a cooperative agreement mechanism. As described, this generally indicates substantial involvement by the funding agency (USAID) during implementation, compared to a standard grant.

7. What type of award is this?

The opportunity is described as a discretionary award using a cooperative agreement mechanism.

8. How many awards did USAID anticipate making?

USAID anticipated making one award.

9. What is the estimated total funding amount?

The estimated total funding amount was up to USD 15,000,000.

10. What is the maximum (ceiling) award amount?

The award ceiling is USD 15,000,000.

11. Is there a minimum (floor) award amount?

Yes. The award floor is listed as USD 0.

12. Is cost sharing or matching required?

Yes. Cost sharing or matching is required, meaning applicants would need to contribute resources or documented value in accordance with the announcement requirements.

13. Who is eligible to apply?

Eligibility is limited to local Philippine organizations only. The eligible applicant types listed include:

  • Philippine non-governmental organizations (NGOs)
  • Local private for-profit companies that are willing to forego profit under the award
  • Universities or colleges that meet the criteria stated in the full announcement

14. Are non-Philippine (foreign) organizations eligible to apply?

No. Based on the information provided, eligibility is limited to local Philippine organizations only.

15. Can a for-profit company apply?

Yes. Local private for-profit companies are listed as eligible, provided they are willing to forego profit under the award.

16. Which CFDA number is associated with this opportunity?

The CFDA number listed is 98.001, USAID Foreign Assistance for Programs Overseas.

17. When was the opportunity posted?

The posting date was June 27, 2012.

18. What was the original application closing date?

The original closing date was August 8, 2012.

19. Was the deadline extended?

Yes. Due to inclement weather, the deadline was extended to August 10, 2012 at 3:00 PM.

20. What happens if an application is submitted after the deadline?

Applications submitted after the deadline were not to be reviewed.

21. Where could applicants access the full announcement?

The listing referenced Grants.gov as the place to access the full announcement.

22. Who is the contact person for questions or support?

The contact person provided is Gracelda M. Laspinas, Acquisition and Assistance Specialist at USAID Manila.

23. What email address is listed for the opportunity contact?

The email address provided is manilahpdp2@usaid.gov.

24. What does “institutionalization of a multi-sectoral health policy institution” imply in this opportunity?

Based on the description, it signals an intent to create or strengthen a durable policy platform that includes multiple sectors (not only health) to coordinate and sustain health policy development over the long term.

25. What kinds of activities are implied under “policy monitoring and evaluation” for HPDP2?

The opportunity describes monitoring and evaluation as tracking whether policies are being implemented as intended, measuring results, and identifying changes needed to improve performance and accountability.

26. What kinds of activities are implied under “capacity building” for HPDP2?

The opportunity describes capacity building as strengthening the skills, tools, and processes that government and partner institutions need to implement health sector reforms more effectively.

Browse more opportunities from the same agency: Philippines USAID Manila

Browse more opportunities from the same category: Health

Next opportunity: Landbird Monitoring 2012 North Coast Cascades Network

Previous opportunity: BLM Washington Office Intern

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA 492 12 000030

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA 492 12 000030) also looked into and applied for these:

Funding Opportunity
Emergency Medical Services for Children (EMSC) State Partnership Grant Program Apply for HRSA 13 201

Funding Number: HRSA 13 201
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Research on Psychopathology In Intellectual Disabilities (R01) Apply for PA 12 219

Funding Number: PA 12 219
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
PPHF 2012 Cooperative Agreements for Prescription Drug Monitoring Program (PDMP) Electronic Health Record (EHR) Integration and Interoperability Expansion (PPHF 2012) Apply for TI 12 011

Funding Number: TI 12 011
Agency: Substance Abuse Mental Health Services Adminis.
Category: Health
Funding Amount: $225,000
Cooperative Agreement to Support Establishment of the Affordable Care Acts Health Insurance Exchanges Apply for IE HBE 12 001

Funding Number: IE HBE 12 001
Agency: CMS Consumer Information Insurance Oversight
Category: Health
Funding Amount: Case Dependent
NIH Directors Transformative Research Awards (R01) Apply for RFA RM 12 017

Funding Number: RFA RM 12 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Dimensional Approaches to Research Classification in Psychiatric Disorders (R01) Apply for RFA MH 13 080

Funding Number: RFA MH 13 080
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Cooperative Agreement on Immunization with the World Health Organization (WHO) Apply for CDC RFA GH13 1301

Funding Number: CDC RFA GH13 1301
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
National Indian Health Outreach Apply for HHS 2012 IHS NIHOE 0002

Funding Number: HHS 2012 IHS NIHOE 0002
Agency: Indian Health Service
Category: Health
Funding Amount: $150,000
PPHF 2012 National Public Health Improvement Initative (NPHII) Capacity Building Assistance to Strengthen Public Health Infrastructure and Performance financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA CD10 101103PPHF12

Funding Number: CDC RFA CD10 101103PPHF12
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
PPHF 2012 Health Care Surveillance/Health Statistics Surveillance Program Announcement Behavioral Risk Factor Surveillance System Financed in part by 2012 Prevention and Public Health Funds Apply for CDC RFA SO11 11010201PPHF12

Funding Number: CDC RFA SO11 11010201PPHF12
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $200,000
PPHF 2012 Health Care Surveillance/Health Statistics Surveillance Program Announcement Behavioral Risk Factor Surveillance System (Pacific Jurisdictions) Financed in Part by 2012 Prevention and Public Health Funds Apply for CDC RFA SO11 11020201PPHF12

Funding Number: CDC RFA SO11 11020201PPHF12
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $100,000
Tuberculosis Regional Training and Medical Consultation Centers Apply for CDC RFA PS13 1304

Funding Number: CDC RFA PS13 1304
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $1,398,944
Limited Competition National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24) Apply for RFA MH 13 070

Funding Number: RFA MH 13 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National NeuroAIDS Tissue Consortium (NNTC) Data Coordinating Center (DCC) (U24) Apply for RFA MH 13 071

Funding Number: RFA MH 13 071
Agency: National Institutes of Health
Category: Health
Funding Amount: $600,000
NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01) Apply for RFA AR 13 004

Funding Number: RFA AR 13 004
Agency: National Institutes of Health
Category: Health
Funding Amount: $150,000
NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research (U54) Apply for RFA MD 12 007

Funding Number: RFA MD 12 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Institutional Clinical and Translational Science Award (U54) Apply for RFA TR 12 006

Funding Number: RFA TR 12 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Apply for HRSA 12 156

Funding Number: HRSA 12 156
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $3,000,000
Identification and Analysis of Causal Variants Follow Up on Genome Wide Association Studies for Arthritis and Musculoskeletal and Skin Diseases (R21) Apply for PAR 12 230

Funding Number: PAR 12 230
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Identification and Analysis of Causal Variants Follow Up on Genome Wide Association Studies for Arthritis and Musculoskeletal and Skin Diseases (R01) Apply for PAR 12 236

Funding Number: PAR 12 236
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA 492 12 000030", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.